• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CAMP

CAMP

CAMP4 Therapeutics Corporation

NASDAQHealthcareBiotechnologyUS

USD3.98

-0.06 (-1.49%)

Rating:C-

Company Profile

CEO

Joshua Mandel-Brehm

IPO Date

2024-10-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$3.99

Prev. Close

$4.04

Day Low

$3.90

Day High

$4.17

52W Low

$1.30

52W High

$7.75

Market Cap

$0.08B

Volume

0.09M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

39.6%

Avg Negative

11.1%

Avg Neutral

49.5%

News Feed

CalAmp To Participate at the Jefferies Semiconductor, IT Hardware & Communications Infrastructure Summit on August 31, 2021

PRNewsWire·8/20/2021·↑ positive

CalAmp Releases New iOn Xtreme Temperature Tag to Monitor Pharmaceutical and Biological Shipments

PRNewsWire·8/19/2021·↑ positive

CalAmp Reaches Global Milestone with Over $1.5 Billion Worth of Stolen Vehicle Recoveries to Date

PRNewsWire·8/12/2021·↑ positive

CalAmp To Participate at Upcoming Financial Conferences

PRNewsWire·7/27/2021·↑ positive

CalAmp's LoJack® Italia and Koelliker Join Forces to Connect and Protect New EV Commercial Vehicles with LoJack Technology

PRNewsWire·7/22/2021·↑ positive

CalAmp iOn™ Awarded 2021 IoT Evolution Product of the Year Award

PRNewsWire·7/14/2021·↑ positive

CalAmp Corp. (CAMP) CEO Jeff Gardner on Q1 2022 Results - Earnings Call Transcript

Seeking Alpha·6/24/2021·↓ negative

CalAmp: Q1 Earnings Insights

Benzinga·6/24/2021·↓ negative

CalAmp Reports First Quarter Fiscal Year 2022 Financial Results

PRNewsWire·6/24/2021·↑ positive

CalAmp's Tracker and cap hpi Partner to Help Car Dealers Uncover Hidden Revenue Opportunities

PRNewsWire·6/22/2021·↑ positive